Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.US FDA has approved Watson Pharmaceuticals' abbreviated new drug application (ANDA) for Oxycodone and Acetaminophen tablets, USP 7.5 mg/500 mg and 10 mg/650 mg.
Subscribe to our email newsletter
The tablets are the generic equivalent to Endo Pharmaceuticals’ Percocet tablets to treat moderate to moderately severe pain.
The tablet will be manufactured at Watson’s Miami, Florida facility in US.
Headquartered in Corona, US, Watson Pharmaceuticals develops, manufactures and sells proprietary and off-patent pharmaceutical products.